612 JOURNAL OF COSMETIC SCIENCE circumstances such as breastfeeding, where between 80 to 90% of women have pain or fissures due to friction and suction, which compromises the barrier and may be the cause of the interruption of said feeding (3). These alterations not only represent an important alteration in the quality of life of patients but also imply the modification of the absorption of drugs or cosmetics, which makes the preservation of the cutaneous barrier of vital importance not only in healthy skin but also on diseased skin (4). Genital lichen sclerosus is a chronic, inflammatory disease that most frequently affects women of all ages (5), producing a great impact on quality of life and sexual health (6), and can progress to cancer. Erosions and itching may appear (7). It is recommended to avoid the use of irritating substances and perfumes (8). Persistent nipple pain is one of the most common causes of cessation of breastfeeding (9). The sensitive skin syndrome is characterized by the presence of subjective symptoms (burning, itching, stinging, pruritus, and tingling sensations) without any clinical signs on the skin. Sensitive skin is a broad term applied to hypersensitive, reactive, intolerant, or hyperexcitable skin, and used to define some characteristics of the skin rather than a medical diagnosis. Sensitive skin is associated with different dermal conditions and precipitating factors, and the underlying pathophysiological mechanisms are not fully understood (10,11). The use of cosmetics that restore the barrier function and decrease the reactivity is recommended (1). Centella asiatica extract is a rich source of natural bioactive substances, particularly triterpenoid saponins known as centelloids (12). The main compounds are the triterpenes asiatic acid and madecassic acid, and their derived triterpene (i.e., ester glycosides, asiaticoside, and madecassoside) (13,14). The triterpenic genin and asiaticoside contents of the purified extract have been shown to offer specific dermatological benefits related to skin healing and regeneration, increasing collagen synthesis and intracellular fibronectin, promoting fibroblast formation, stimulating hyaluronic acid synthesis, and improving cutaneous connective tissue regeneration (14–17). Asiaticoside is the fundamental active substance of C asiatica (18), and is responsible for most of its antioxidant, anti-inflammatory, immune modulating, and tissue repair properties (19,20). Asiatic acid in turn intervenes in molecular mechanisms related to enzymatic processes, growth factors, transcription factors, apoptotic proteins, and cell signaling pathways (21). Studies based on in vitro and in vivo models have found asiatic acid to prevent skin aging caused by ultraviolet radiation, suppress the accumulation of collagen produced by fibroblasts in the context of keloid scar formation, and favor wound epithelization (21). As a result of all this, formulations based on C asiatica extracts have been widely used over the years for different indicators, including improved healing of minor wounds and burns, hypertrophic scars, pregnancy stretch marks, and psoriatic or scleroderma lesions (22–24), and as antiaging products (25,26). Cosmetological research has evidenced the great reparatory capacity of C asiatica extracts, thanks to the stimulation of collagen synthesis, accelerating reconstruction, and renewal of the epidermis (27). In this regard, a product has been developed, combining the properties of asiaticoside and asiatic acid contained in C asiatica, in the form of a light-textured and rapidly absorbing cream (Blastoactiva™, Almirall, S.A., Barcelona, Spain), with different indications. Although this is a marketed and dermatologically tested product particularly indicated for the treatment of damaged skin with altered barrier function for adults, children, and babies 3 mo and older, no synthesis of the scientific evidence on its efficacy, tolerability, and acceptability under normal conditions of daily use has been published to date. The present
613 CENTELLA ASIATICA EXTRACTS IN SKIN REPAIR PRODUCTS article describes the results of the clinical and laboratory tests made with Blastoactiva™, formulated with two main active constituents from C asiatica: asiaticoside and asiatic acid, which contribute to enhance skin repair and regeneration. Thus, based on the properties of asiaticoside and asiatic acid, the cosmetic indications of Blastoactiva™ include the repair of skin damaged by dryness (xerosis), superficial acne scarring, and superficial aggression produced by physical agents (e.g., cold, wind, pollution, solar exposure), and cosmetic treatments (e.g., laser, peeling, depilation and epilation, tattoos, and phototherapy sessions). METHODS AND RESULTS IN VITRO AND IN VIVO EVALUATION OF TOLERABILITY In vitro evaluation of eye irritant potential. The in vitro evaluation of the eye irritant potential of Blastoactiva™ was carried out based on a test involving application of the product in the chorioallantoic membrane (CAM) of 10-day incubated chick embryos. This technique constitutes an alternative to animal testing and is similar to that described by Luepke and Kemper (28). Use was made of four white Leghorn chicken eggs (40–70 g) incubated during 10 d under controlled temperature (37.8 ± 1°C) and relative humidity conditions (50–60%) on oscillating plates in the vertical position with the egg air chamber facing upwards. After breaking and sectioning the shell, 300 µL of the product was deposited onto the CAM with a micropipette. After 20 s of contact, the CAM was cleansed with 5 mL of isotonic saline solution. The following characteristics were analyzed over the subsequent 5 min: appearance of hyperemia (appearance of visible capillaries or dilatation and reddening of existing capillaries), hemorrhage (diffuse, in layers or punctate), and coagulation (opacity and/or thrombosis) after ≤30 s, between 30 s and ≤2 min, and 2 min and ≤5 min after contact with the CAM. The cases of hyperemia, hemorrhage, and coagulation were summed for each egg with a total score of 0 to 21 and classified as: 1 is practically nonirritating ≥1 to 5 is slightly irritating ≥5 and 9 is moderately irritating and ≥9 is irritating. Negative and positive controls were included in the form of a 0.8% NaCl solution and different concentrations of sodium lauryl sulfate, respectively. The results obtained in vitro, with a mean (± standard deviation) of 0 ± 0 for hyperemia, hemorrhage, and coagulation phenomena, showed the product to cause practically no eye irritation. Allergenic potential. The allergenic potential of Blastoactiva™ was studied in 50 volunteers of either gender and between 18 and 70 yr of age with a Fitzpatrick I–V skin phototype and sensitive skin. For this purpose, use was made of the Human Repeat Insult Patch Test (HRIPT) described by Marzulli in 1973 (29). The study was approved by the evaluation committee of EVIC Romania (Bucharest, Romania) (registry CI-313/08). In accordance with standard practice of the HRIPT, the volunteers were exposed to the study product using adhesive patches (Finn Chamber standard®, Merck spol s.r.o., Bratislava, The Slovak Republic) with an aluminum cap containing 20 μL (∼20 mg) of Blastoactiva™. The patches were affixed to a zone of the skin with hypoallergenic adhesive tape (Scanpor® [Norgesplaster, Granlivegen 21, NO-4707 Vennesla Norway]) with an internal diameter of 8 mm and surface area of 50 mm2). Another 20 additional products were tested in parallel in the same way.
Purchased for the exclusive use of nofirst nolast (unknown) From: SCC Media Library & Resource Center (library.scconline.org)














































































